Home 22. Humira (Adalimumab)

Humira (Adalimumab)

Humira has been used in the treatment of rheumatoid arthritis, psroriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis and juvenile idiopathic arthritis.  Humira is marketed by Abbott Laboratories.

Use of Humira can result in a number of side effects, including serious blood disorders; infections, as tuberculosis; lymphoma and solid tissue cancers; serious liver injury; demyelinating central nervous system disorders; and cardiac failure.  Due to the risks of using Humira, the FDA has issued a black box warning instructing health care providers to carefully monitoring patients who are taking Humira.